127 related articles for article (PubMed ID: 21757934)
1. Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer.
Nagarajan R; Margolis D; McClure T; Raman S; Thomas MA
Med Princ Pract; 2011; 20(5):444-8. PubMed ID: 21757934
[TBL] [Abstract][Full Text] [Related]
2. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores.
Nagarajan R; Margolis D; Raman S; Sarma MK; Sheng K; King CR; Verma G; Sayre J; Reiter RE; Thomas MA
J Magn Reson Imaging; 2012 Sep; 36(3):697-703. PubMed ID: 22581787
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer.
Chung HT; Noworolski SM; Kurhanewicz J; Weinberg V; Roach Iii M
BJU Int; 2011 Oct; 108(8 Pt 2):E164-70. PubMed ID: 21435153
[TBL] [Abstract][Full Text] [Related]
4. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
Nagarajan R; Gomez AM; Raman SS; Margolis DJ; McClure T; Thomas MA
NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
[TBL] [Abstract][Full Text] [Related]
5. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
[TBL] [Abstract][Full Text] [Related]
6. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
[TBL] [Abstract][Full Text] [Related]
7. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
[TBL] [Abstract][Full Text] [Related]
8. Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning.
Wu X; Dibiase SJ; Gullapalli R; Yu CX
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1577-83. PubMed ID: 15050339
[TBL] [Abstract][Full Text] [Related]
9. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J
BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490
[TBL] [Abstract][Full Text] [Related]
10. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S
Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
12. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
[TBL] [Abstract][Full Text] [Related]
14. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T.
Luttje MP; Italiaander MG; Arteaga de Castro CS; van der Kemp WJ; Luijten PR; van Vulpen M; van der Heide UA; Klomp DW
Magn Reson Med; 2014 Dec; 72(6):1516-21. PubMed ID: 24357271
[TBL] [Abstract][Full Text] [Related]
15. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
16. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
[TBL] [Abstract][Full Text] [Related]
17. MR spectroscopy of the human prostate using surface coil at 3 T: metabolite ratios, age-dependent effects, and diagnostic possibilities.
Weis J; Jorulf H; Bergman A; Ortiz-Nieto F; Häggman M; Ahlström H
J Magn Reson Imaging; 2011 Dec; 34(6):1277-84. PubMed ID: 21954046
[TBL] [Abstract][Full Text] [Related]
18. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.
Wefer AE; Hricak H; Vigneron DB; Coakley FV; Lu Y; Wefer J; Mueller-Lisse U; Carroll PR; Kurhanewicz J
J Urol; 2000 Aug; 164(2):400-4. PubMed ID: 10893595
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
